Speaker illustration

Doctor Suguru Migita

Nihon University, Tokyo (Japan)

Initial pathological responses of third-generation everolimus-eluting stents implantation: comparison with second-generation everolimus-eluting stents.

Event: ESC Congress 2019

Topic: Outcome

Session: Percutaneous coronary syndrome: pharma and devices

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb